Home / Market Reports / Medical Care / Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030

Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030

Global Point of Care Diagnostics (POCD) Market Growth (Status and Outlook) 2024-2030

Product Code:793472

Published Date: Jan 02,2024

Pages: 150

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

According to our LPI (LP Information) latest study, the global Point of Care Diagnostics (POCD) market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the Point of Care Diagnostics (POCD) is forecast to a readjusted size of US$ 34320 million by 2030 with a CAGR of 4.6% during review period. 
The research report highlights the growth potential of the global Point of Care Diagnostics (POCD) market.  Point of Care Diagnostics (POCD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Point of Care Diagnostics (POCD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Point of Care Diagnostics (POCD) market.

Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:
The report on Point of Care Diagnostics (POCD) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Point of Care Diagnostics (POCD) market. It may include historical data, market segmentation by Type (e.g., Blood Glucose Testing, Infectious Diseases Testing), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Point of Care Diagnostics (POCD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Point of Care Diagnostics (POCD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Point of Care Diagnostics (POCD) industry. This include advancements in Point of Care Diagnostics (POCD) technology, Point of Care Diagnostics (POCD) new entrants, Point of Care Diagnostics (POCD) new investment, and other innovations that are shaping the future of Point of Care Diagnostics (POCD).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Point of Care Diagnostics (POCD) market. It includes factors influencing customer ' purchasing decisions, preferences for Point of Care Diagnostics (POCD) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Point of Care Diagnostics (POCD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Point of Care Diagnostics (POCD) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Point of Care Diagnostics (POCD) market. 
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Point of Care Diagnostics (POCD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Point of Care Diagnostics (POCD) market.

Market Segmentation:
Point of Care Diagnostics (POCD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
    Blood Glucose Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Pregnancy and Fertility Testing
    Blood Gas/Electrolytes Testing
    Tumor Markers Testing
    Urinalysis Testing
    Cholesterol Testing
    Others

Segmentation by application
    Clinics
    Hospitals
    Assisted Living Healthcare Facilities
    Laboratory

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Alere
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Siemens Healthcare
    Danaher
    QIAGEN
    Bayer Healthcare
    Beckman Coulter
    Nipro Diagnostics
    Bio-Rad Laboratories
    Nova Biomedical
    BioMerieux
    Quidel
    Helena Laboratories
    OraSure Technologies
    Accriva
    Abaxis
    Chembio Diagnostics
    Trinity Biotech
    Instrumentation Laboratory
    Sekisui Diagnostics